J. Wilson

发表

Analysis of intraprostatic therapeutic effects in prostate cancer patients using [(11)C]-choline pet/ct after external-beam radiation therapy.

M. Wuest, R. Pearcey, D. Robinson, 2013, Current oncology.

Phase I and pharmacokinetic trial of aminopterin in patients with refractory malignancies.

N. Winick, B. Kamen, M. Marling-Cason, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose cyclophosphamide, carboplatin, and etoposide with autologous stem cell rescue in patients with breast cancer.

Steven M. Pincus, B. Lembersky, E. Ball, 1996, American journal of clinical oncology.

Autologous bone marrow transplantation for acute myeloid leukemia in remission or first relapse using monoclonal antibody-purged marrow: results of phase II studies with long-term follow-up

E. Ball, S. Neudorf, J. Wilson, 2000, Bone Marrow Transplantation.

High-dose trimetrexate and minimal-dose leucovorin: a case for selective protection?

B. Kamen, J. Holcenberg, J. Wilson, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

D. Osoba, I. Tannock, M. Stockler, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose chemotherapy and autologous stem cell support followed by posttransplantation doxorubicin as initial therapy for metastatic breast cancer.

B. Lembersky, S. Pincus, E. Ball, 1997, Clinical Cancer Research.

The use of counterflow centrifugal elutriation for the depletion of T cells from unrelated donor bone marrow.

A. Donnenberg, S. Pincus, E. Ball, 1997, Journal of hematotherapy.

Evaluation of monoclonal antibody-mediated anti-acute myeloid leukemia immunotherapy in a SCID/hu model.

S. Swerdlow, A. Donnenberg, J. Chen, 1996, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.

Factors influencing mobilization and engraftment in patients with metastatic breast cancer undergoing PBSC transplantation.

A. Donnenberg, E. Ball, J. Lister, 1999, Journal of hematotherapy.

Cyclophosphamide and fluorouracil combined with mitoxantrone versus doxorubicin for breast cancer: superiority of doxorubicin.

K. Pritchard, M. Trudeau, D. Stewart, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Busulfan and cyclophosphamide (BU/CY2) as preparative regimen for patients with lymphoma

E. Ball, J. Lister, M. deMagalhaes-Silverman, 1997, Bone Marrow Transplantation.

Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer.

D. Osoba, I. Tannock, K. Murphy, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Target volume definition in conformal radiotherapy for prostate cancer: quality assurance in the MRC RT-01 trial.

D. Dearnaley, V. Khoo, B. Seddon, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The importance of dose scheduling with mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancer.

K. Bélanger, L. Yelle, J. Latreille, 1994, European Journal of Cancer.

A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project.

A. Warth, A. Marchetti, L. Bubendorf, 2019, Lung cancer.